Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-300
Closed -$5K – 1173
2020
Q2
$5K Hold
300
– – ﹤0.01% 1610
2020
Q1
$3K Buy
+300
New +$6.04K ﹤0.01% 1633
2019
Q4
– Sell
-121,900
Closed -$2.8M – 1621
2019
Q3
$2.8M Hold
121,900
– – 0.03% 442
2019
Q2
$2.96M Buy
+121,900
New +$2.51M 0.03% 442
2019
Q1
– Sell
-24
Closed -$1K – 1641
2018
Q4
$1K Hold
24
– – ﹤0.01% 1686
2018
Q3
$1K Hold
24
– – ﹤0.01% 1689
2018
Q2
$1K Hold
24
– – ﹤0.01% 1707
2018
Q1
$1K Hold
24
– – ﹤0.01% 1707
2017
Q4
$2K Hold
24
– – ﹤0.01% 1677
2017
Q3
$2K Hold
24
– – ﹤0.01% 1655
2017
Q2
$2K Hold
24
– – ﹤0.01% 1663
2017
Q1
$2K Hold
24
– – ﹤0.01% 1698
2016
Q4
$1K Buy
+24
New +$1.27K ﹤0.01% 1521

Other funds holding ADNT

QS Investors's ADNT Position: Q3 2020 in Review

QS Investors sold out of Adient (ADNT) in Q3 2020, closing a stake of 300 shares — an estimated $5K sold.

QS Investors first reported a position in ADNT in Q4 2016 and held it in 13 quarters. The position peaked at $2.96M in Q2 2019. 272 funds tracked by Wall St. Rank hold ADNT as of Q3 2020.

  • QS Investors reported no remaining Adient position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 300 Adient shares in Q3 2020, an estimated $5K.
  • QS Investors first reported a position in Adient in Q4 2016 and held it in 13 quarters.
  • QS Investors's Adient position peaked at $2.96M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Adient as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.